Vertex Announces European Commission Approval of ALYFTREK®, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis
-
01/05/2025, 13:50
-
ansa.it
0
Scopri altro
- ieri, 21:44
-
repubblica.it
-
0
- 01/07/2025, 13:50
-
ansa.it
-
0
- 01/07/2025, 13:26
-
ansa.it
-
0
- 01/07/2025, 13:19
-
ansa.it
-
0
- 01/07/2025, 12:59
-
repubblica.it
-
0
- 01/07/2025, 12:59
-
ansa.it
-
0
- 01/07/2025, 12:43
-
ansa.it
-
0
- 01/07/2025, 12:36
-
money.it
-
0
Nessun commento